MAGE-3 peptide/chitosan-deoxycholic acid vaccine-loaded nanoparticles have been shown to simulate an antitumor immune response and tumor regression in mouse models of gastric cancer [46]. The gene discussed is MAGEA3; the disease is neoplasm.